Please assess the completion status of the following clinical trial:

Trial Title: Effects of Atorvastatin 10 mg Versus 40 mg in Eight Months Follow-up Coronary Flow Reserve and Bone Marrow Stem Cell Mobilization in Patients With Acute Myocardial Infarction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age 18 years and above~* Gender eligible for study both~* Patients with acute myocardial infarction requiring sirolimus-eluting stent implantation~* Acute myocardial infarction affecting proximal to mid coronary arteries~* No lesions greater than 50 percent diameter stenosis distal to the stent implantation~* Patients with informed consent~Exclusion Criteria:~* Left main lesion~* Killip Class IV acute myocardial infarction~* Patients with current use of any statin~* Tortuous lesion with difficult intracoronary Doppler wiring~* Acute myocardial infarction affecting distal coronary arteries~* Acute myocardial infarction affecting branching coronary arteries~* The use of thiazolidinediones within 3 months~* Previous history of PCI or bypass surgery on infarct-related coronary artery~* Patients with any contraindications to the treatment of atorvastatin~* Pregnant or lactating patients~* Chronic alcohol or drug abuse~* Hepatic dysfunction (3 times above upper normal limit 5 days after AMI)~* Renal dysfunction (Creatinine greater than 2.0 mg/dL)~* Severe Heart failure (EF less than 25 percent)~* Expected life expectancy of less thna 1 year

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).